We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCHP icon
301
Microchip Technology
MCHP
$38.7B
$668K 0.01%
7,300
– –
GS icon
302
Goldman Sachs
GS
$284B
$662K ﹤0.01%
1,464
– –
MDLZ icon
303
Mondelez International
MDLZ
$79.4B
$654K ﹤0.01%
9,998
-31
-0.3% -$2.13K
CARR icon
304
Carrier Global
CARR
$45.8B
$643K ﹤0.01%
10,187
-300
-3% -$18.4K
CSX icon
305
CSX Corp
CSX
$90.2B
$625K ﹤0.01%
18,672
-40
-0.2% -$1.36K
BA icon
306
Boeing
BA
$165B
$624K ﹤0.01%
3,430
-200
-6% -$35.6K
ALV icon
307
Autoliv
ALV
$8.54B
$613K ﹤0.01%
5,730
-275
-5% -$32.7K
QUAL icon
308
iShares MSCI USA Quality Factor ETF
QUAL
$46.6B
$613K ﹤0.01%
3,590
– –
FWRD icon
309
Forward Air
FWRD
$561M
$611K ﹤0.01%
+32,116
New +$663K
SJM icon
310
J.M. Smucker
SJM
$13B
$603K ﹤0.01%
5,530
– –
BMY icon
311
Bristol-Myers Squibb
BMY
$130B
$590K ﹤0.01%
14,211
-100
-0.7% -$4.47K
TD icon
312
Toronto Dominion Bank
TD
$199B
$580K ﹤0.01%
10,550
-1,000
-9% -$56.6K
IBM icon
313
IBM
IBM
$234B
$571K ﹤0.01%
3,302
-45
-1% -$7.82K
HCA icon
314
HCA Healthcare
HCA
$91.7B
$568K ﹤0.01%
1,768
– –
CRM icon
315
Salesforce
CRM
$211B
$524K ﹤0.01%
2,039
-24
-1% -$6.42K
VRTX icon
316
Vertex Pharmaceuticals
VRTX
$130B
$520K ﹤0.01%
1,110
– –
SHW icon
317
Sherwin-Williams
SHW
$78.4B
$514K ﹤0.01%
1,724
– –
WAB icon
318
Wabtec
WAB
$47.1B
$512K ﹤0.01%
3,241
-4
-0.1% -$639
CAT icon
319
Caterpillar
CAT
$359B
$511K ﹤0.01%
1,534
– –
VEU icon
320
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$498K ﹤0.01%
8,491
-136
-2% -$7.98K
UL icon
321
Unilever
UL
$135B
$493K ﹤0.01%
7,973
+81
+1% +$4.79K
CSL icon
322
Carlisle Companies
CSL
$12.9B
$486K ﹤0.01%
1,200
– –
SCHW
323
Charles Schwab
SCHW
$187B
$482K ﹤0.01%
6,546
-109
-2% -$8.05K
VT icon
324
Vanguard Total World Stock ETF
VT
$80.6B
$476K ﹤0.01%
4,225
– –
XYL icon
325
Xylem
XYL
$25B
$464K ﹤0.01%
3,418
– –
11 12
13
14 15

Similar funds

MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.